RxDoctor Payments Data

Daniel Olney, MD

Otolaryngology/Facial Plastic Surgery · Iowa City, IANPI 1932155900

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Integra Lifesciences Corporation at 38.5% of the total.

$1,016in general payments, 2019–2025

Across 36 payments — averaging $28.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$391
  • Acclarent, Inc$144
  • Sanofi$103
  • Stryker$93
  • Itamar Medical Inc$42
  • Intersect ENT, Inc.$39
  • plus $204 from 9 others

What the payments were for

  • Food & beverage$1,016100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in Iowato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$352,151
Medicare patients
593
Services billed
4,739

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Epinephrine17$3,251
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth22$2,477
Ipratropium Bromide75$1,777
Fluocinolone Acetonide Oil38$1,757
Omeprazole224$1,480
Fluticasone Propionate82$917
Methylprednisolone99$638
Pantoprazole Sodium64$492
Cefdinir16$426
Azelastine Hcl23$343
Famotidine42$210
Triamcinolone Acetonide40$160
Ropinirole Hcl11$138
Mupirocin16$137
Azithromycin34$90

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Iowa City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →